This 90-minute webinar was created for physicians, nurses, and other health professionals who treat and case manage patients with active TB. The webinar introduced the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. This training highlighted the guidelines development process, the key changes in recommendations, and discussed the evidence supporting the changes. The webinar was originally presented on November 4, 2016. This training was jointly sponsored by all 5 RTMCCs.
Which papers have provided the most interesting recent advances in tuberculosis research? Which new discoveries in pathogenesis, epidemiology, drug discovery or vaccine development have been the most important or are likely to have the highest impact to the field?
- nm0307-276.pdf (174.92 KB)
This article, published in May 2006 in the American Journal of Respiratory and Critical Care Medicine, presents research that demonstrates that if a patient is underweight or does not have a significant weight gain while on therapy the relapse rate of TB is much higher than in well nourished TB patients.easily identified, even in resource-poor settings.
- KhanAJRCCMWtTB07.pdf (141.24 KB)